Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
JBSS Transcript
John B. Sanfilippo & Son, Inc. (JBSS) Q3 2026 Earnings Call Transcript
Unknown4-30
The earnings call highlights record sales growth and improved channel performance, suggesting positive momentum. However, the consistency in total volume compared to last year and acknowledgment of inherent risks indicate potential challenges in sustaining growth. The absence of discussion on shareholder returns and unclear management responses in the Q&A add uncertainty. Given the company's market cap, the stock price is likely to remain stable, with no strong catalysts for a significant move in either direction, leading to a 'Neutral' sentiment rating.
John B. Sanfilippo & Son, Inc. (JBSS) Q2 2026 Earnings Call Transcript
Positive1-30
The earnings call reveals strong financial performance with a 32% increase in EPS and a special dividend, indicating financial strength and commitment to shareholder returns. Despite risks like higher commodity costs and shifting consumer behavior, the company's strategic focus on innovation, operational efficiency, and market expansion is promising. The Q&A session showed management's transparency and confidence in handling challenges. Given the company's market cap and the positive financial outlook, a positive stock price movement of 2% to 8% is likely in the next two weeks.
John B. Sanfilippo & Son, Inc. (JBSS) Q1 2026 Earnings Call Transcript
Positive10-30
The earnings call revealed strong financial performance with increased net sales, gross profit, and net income. Despite challenges like commodity inflation and lost distribution, the company managed to improve margins and reduce operating expenses. The special cash dividend also indicates confidence in financial health. The Q&A highlighted management's transparency and adaptability to consumer shifts. Market cap suggests moderate sensitivity to news, leading to a positive sentiment prediction (2% to 8%) over the next two weeks.
John B. Sanfilippo & Son, Inc. (JBSS) Q4 2025 Earnings Call Transcript
Unknown8-21
The earnings call presents a mixed picture. While there are positive elements such as record net sales, increased dividends, and EPS growth, there are also significant concerns. These include declining sales volume, increased costs, and macroeconomic uncertainties impacting margins. The Q&A section did not provide additional clarity, and the market cap suggests moderate sensitivity to these factors. Overall, the positives and negatives balance each other out, leading to a neutral sentiment prediction for the stock price movement over the next two weeks.
JBSS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
